These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32594465)

  • 21. Treatment of oromandibular dystonia with botulinum toxin A improves apnea in a teenager with quadriplegic cerebral palsy: A case report.
    Roberts J; Tenaglia A; Bellissimo E; Kim H
    J Pediatr Rehabil Med; 2024; 17(1):125-129. PubMed ID: 37522227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oromandibular dystonia associated with SCA36.
    Miyashiro A; Sugihara K; Kawarai T; Miyamoto R; Izumi Y; Morino H; Maruyama H; Orlacchio A; Kawakami H; Kaji R
    Mov Disord; 2013 Apr; 28(4):558-9. PubMed ID: 23390045
    [No Abstract]   [Full Text] [Related]  

  • 23. Haptic Feedback Manipulation During Botulinum Toxin Injection Therapy for Focal Hand Dystonia Patients: A Possible New Assistive Strategy.
    Atashzar SF; Shahbazi M; Ward C; Samotus O; Delrobaei M; Rahimi F; Lee J; Jackman M; Jog MS; Patel RV
    IEEE Trans Haptics; 2016; 9(4):523-535. PubMed ID: 27552765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of oromandibular dystonia with botulinum A toxin: a series of cases.
    Teemul TA; Patel R; Kanatas A; Carter LM
    Br J Oral Maxillofac Surg; 2016 Dec; 54(10):1080-1084. PubMed ID: 27776922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue.
    Nastasi L; Mostile G; Nicoletti A; Zappia M; Reggio E; Catania S
    J Neurol; 2016 Sep; 263(9):1702-8. PubMed ID: 27278063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of idiopathic lower limb dystonia treated with combined botulinum toxin and phenol nerve block.
    Bianchini E; Massimiani A; Bemporad J; Giovannelli M
    Acta Neurol Belg; 2024 Jun; 124(3):1095-1097. PubMed ID: 38133850
    [No Abstract]   [Full Text] [Related]  

  • 27. [Indications and management of botulinum toxin].
    Singer C
    Rev Neurol; 1999 Jul 16-31; 29(2):157-62. PubMed ID: 10528331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Botulin A toxin: a highly effective drug in the treatment of focal dystonia].
    Timerbaeva SL; Ivanova-Smolenskaia IA; Markova ED; Poleshchuk VV; Karapetian MV; Rebrova OIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(5):32-5. PubMed ID: 10849964
    [No Abstract]   [Full Text] [Related]  

  • 30. Surgical management of persistent oromandibular dystonia of the temporalis muscle.
    Dimitroulis G
    Int J Oral Maxillofac Surg; 2011 Feb; 40(2):222-4. PubMed ID: 20832993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Botulism toxin in practice].
    Durand A; Serment G
    Ann Readapt Med Phys; 2003 Jul; 46(6):386-8. PubMed ID: 12928147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the Psychosocial Impact of Botulinum Toxin Type A Injections for Individuals With Oromandibular Dystonia: A Qualitative Study of Patients' Experiences.
    Page AD; Elhayek N; Baylor C; Adams S; Jog M; Yorkston K
    Am J Speech Lang Pathol; 2021 Jun; 30(3S):1314-1328. PubMed ID: 33647215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of focal dystonia involving multiple muscles with a single injection of botulinum toxin A to 1 muscle: A case report.
    Lee SY; Lee HD; Cho YS; Han SH
    Medicine (Baltimore); 2018 Oct; 97(42):e12785. PubMed ID: 30334967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins.
    Hassell TJW; Charles D
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32331272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trial.
    Vizcarra JA; Lopez-Castellanos JR; Dwivedi AK; Schmerler DA; Ries S; Espay AJ
    Parkinsonism Relat Disord; 2019 Jun; 63():174-178. PubMed ID: 30777651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-Rated Communication-Related Quality of Life of Individuals With Oromandibular Dystonia Receiving Botulinum Toxin Injections.
    Page AD; Siegel L; Jog M
    Am J Speech Lang Pathol; 2017 Jun; 26(2S):674-681. PubMed ID: 28654948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basis of movement control in dystonia and why botulinum toxin should influence it?
    Wagle Shukla A
    Toxicon; 2024 Jan; 237():107251. PubMed ID: 37574115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Botulinum toxin treatment of patients with oromandibular dystonia].
    Erdal J; Werdelin LM; Prytz S; Fuglsang-Frederiksen A; Møller E
    Ugeskr Laeger; 2000 Nov; 162(48):6567-71. PubMed ID: 11187229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incobotulinum toxin A in Parkinson's disease with foot dystonia: A double blind randomized trial.
    Rieu I; Degos B; Castelnovo G; Vial C; Durand E; Pereira B; Simonetta-Moreau M; Sangla S; Fluchère F; Guehl D; Burbaud P; Geny C; Gayraud D; Ory-Magne F; Bouhour F; Llinares E; Derost P; Marques A; Durif F
    Parkinsonism Relat Disord; 2018 Jan; 46():9-15. PubMed ID: 29102441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurophysiological Basis of Deep Brain Stimulation and Botulinum Neurotoxin Injection for Treating Oromandibular Dystonia.
    Maezawa H; Hirata M; Yoshida K
    Toxins (Basel); 2022 Nov; 14(11):. PubMed ID: 36356002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.